Skip to main content
Erschienen in: BMC Nephrology 1/2022

Open Access 01.12.2022 | Case report

A rare case of renal infarction due to heroin and amphetamine abuse: case report

verfasst von: Suhail Khokhar, Daniela Garcia, Rajesh Thirumaran

Erschienen in: BMC Nephrology | Ausgabe 1/2022

Abstract

Background

Renal infarctions as a result of recreational drug use are rare and are commonly associated with cocaine use. Although amphetamines have a similar mechanism of action as cocaine, there are few reports linking them to ischemic events, and only one to renal infarction. Similarly, few reports link heroin use with infarcts, but never in the kidney. Although uncommon, several mechanisms have been implicated in heroin and amphetamine-induced infarction, including vasculopathy, vasculitis and the activation of the coagulation cascade.

Case Presentation

47-year-old female with a past medical history of non-intravenous heroin and amphetamine abuse, chronic obstructive pulmonary disease, hypertension, hyperlipidemia presented with right lower extremity swelling and rash, which was diagnosed as cellulitis and treated appropriately. Incidentally, the patient was found to have an acute kidney injury and further workup identified multiple renal infarcts in the right kidney. The patient had no past medical history of clotting disorders. Blood culture and urine cultures were sterile; autoimmune and hypercoagulable workup were negative. Urinalysis was unremarkable. Urine toxicology was only positive for opiates and amphetamines, which were thought to be the most likely cause of the renal infarct. Patient was lost to outpatient follow up due to noncompliance, but returned to the hospital for re-emergence of her cellulitis, during which no new infarcts were discovered, and the previous renal infarct had scarred over.

Conclusion

There are very few reports of heroin and amphetamine-induced infarctions. This case report describes a rare but important complication of heroin/amphetamine abuse that could be easily overlooked.
Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Background

Renal infarction occurs when blood flow to a region of the kidney is obstructed and the resultant hypoxia causes tissue damage. Atrial fibrillation is the most common risk factor for renal infarction [2]. Symptoms of renal infarction are often flank pain, nausea and vomiting. In addition to radiologic findings, an increase in lactate dehydrogenase, C-reactive protein and impairment of renal function is often noted in patients with renal infarcts [6]. There is only one report of amphetamine-induced renal infarction and none linking heroin to this complication [9]. It is estimated that over one million people abuse heroin or amphetamine in the US, making complications secondary to these drugs an important healthcare issue [5]. Renal infarction has currently limited treatment options and timely detection is of utmost importance.

Case presentation

A 47-year-old woman with past medical history of non-intravenous heroin and amphetamine abuse, tobacco dependence, chronic obstructive pulmonary disease, hypertension, and hyperlipidemia presented to the emergency department with complaints of right lower extremity swelling and rash 1 week prior to arrival. Pain in the leg was reported to be recurrent. She had leukocytosis of 23.9 k/μL (79.7% neutrophils), creatinine of 2.4 mg/dL (with a baseline creatinine of 1 mg/dL), C-reactive protein elevation to 10.8 mg/L. Erythrocyte sedimentation rate was 20. She also had mild elevation of lactic acid to 2.4 and hypotension, both of which resolved after receiving a 1 l bolus of normal saline. Ultrasound of bilateral lower extremities was performed, and no deep venous thrombosis was identified, so patient was admitted for IV antibiotic treatment of right leg cellulitis. Physical exam was only significant for erythema of the right leg up to the mid shin. Blood cultures and urine cultures collected prior to starting antibiotics showed no growth. Renal ultrasound obtained to evaluate the acute kidney injury found a hypoechoic region in the right kidney. MRI of the abdomen identified multiple infarcts with the largest measuring 5 cm in the upper pole and 4 cm in the mid-pole of right kidney (Figs. 1 and 2. MRI of the abdomen was negative for malignancy and just showed benign adrenal adenoma, urine metanephrines were 60 μg/day (ref 58–203 μg/day) and catecholamines were 8 μg/day (ref 15–100 μg/day). These showed a preserved capsular enhancement. Right renal artery and vein were patent. No surrounding edema or diffusion restriction was observed to suggest an abscess. Patient did not complain of any abdominal pain or nausea. Patient denied any history of spontaneous abortions, but noted a family history of blood clots, which prompted a hypercoagulable work up. PT/INR and APTT were within normal limits. Her AST was 20 U/L (Ref 10–40), ALT was 30 U/L (Ref 7–52), total bilirubin was 0.4 mg/dl (Ref 0.2–1.2), and direct bilirubin was 0.1 mg/dl (Ref 0–0.2). Factor V Leiden mutation was not detected. The activity of protein C and S were 114 and 102, respectively, within their normal ranges. Antithrombin III activity was 85, also within normal range. Antiphospholipid antibodies and homocysteine levels were within normal limit. The chance of vasculitis in a patient with an ESR of 20 is very small, but nonetheless, workup for collagen vascular diseases was performed. The patient’s ANA screen was negative and she was also negative for double stranded DNA antibodies. ANCA serology was negative. Rheumatoid factor was negative too. Hepatitis A IgM antibody, B antigen and core IgM antibody, and C antibody and HIV p24 and antibody were negative. 2D echo was performed to rule out cardioembolic sources, and the test was without any abnormalities. EKG showed normal sinus rhythm, no atrial fibrillation, and she denied history of palpitations. She was placed on continuous telemetry and there were no episodes of atrial fibrillation on telemetry. She was diagnosed with amphetamine/heroin induced renal infarct based on exclusion of other possibilities.
The patient was asymptomatic with respect to the renal infarct. Mechanical thrombectomy was not an option considering that no large clots were discovered on imaging. Systemic thrombolysis was also not done because she was outside a likely temporal window of benefit. She was advised regarding drug cessation and was discharged with antibiotics for her cellulitis. She was advised to follow up in the outpatient hematology clinic. While she did not come to the appointment, she did return to the hospital with recurrent pain in her leg a month later. At that time, abdomen CT repeat did not discover any new infarcts, and the previous renal infarct was scarred over.

Discussion and conclusion

Amphetamines are sympathomimetics, like cocaine, and function by increasing synaptic concentrations of monoamines [10]. They can increase heart rate as well as blood pressure via activation of the sympathetic nervous system, which is believed to be the mechanism behind hemorrhagic brain strokes [23]. Users of amphetamines also risk vascular complications such as renal artery aneurysms, renal cortical necrosis, necrotizing renal vasculopathy, or vasculitis [3, 7, 13, 19, 24]. Reports of ischemic events such as myocardial infarction are rare but are present in the literature [1617]. Renal infarctions due to ecstasy use, a type of amphetamine, have been reported only once [9]. Ischemic events secondary to amphetamine use is believed to be primarily driven through induction of thrombosis [20]. Amphetamines have been shown to induce tissue factor expression on the surface of endothelial cells. Tissue factor activates the coagulation pathway by binding factor VII, leading to a coagulation cascade and clot formation [12]. Additionally, amphetamines have been shown to accelerate atherosclerosis, which could further aggravate the prothrombotic state within the vessel [14]. Moreover, there is some evidence to suggest that amphetamine use can lead to vasospasm or vasculitis, which impair blood supply to the organ and creating an environment favorable for an acute ischemic event [8].
Interestingly, heroin as a drug of abuse works via a completely different mechanism than amphetamine. Heroin is an agonist of the mu, kappa, and delta opioid receptors, which upon activation can lead to a diverse set of effects such as analgesia, decreased gastrointestinal motility, and respiratory depression [15]. Despite its different mechanism of action, heroin use has also been tied to the induction of ischemic events. The biggest contributing factor to ischemia in heroin users stems from endocarditis seeding septic emboli; however, this is a complication found only in intravenously abused drugs – not the case in our patient [11]. Heroin use has also been shown to increase vascular stiffness, and there are even reports of heroin-induced cerebral and myocardial infarctions [1, 21, 22]. Dependence on opiates, a drug family which heroin is part of, has also been shown to increase fibrinogen levels, which could predispose one to a higher likelihood of an embolic event [18]. Finally, heroin has been reported to induce hyper-eosinophilic syndrome, which can also lead to thrombosis and has been reported to result in cerebral infarction [4]. In the case of our patient, her eosinophils were 200/μL (normal limit up to 700/μL), ruling out the possibility of the hyper-eosinophilic syndrome.
Our patient did not have clinical symptoms commonly associated with renal infarctions, which made a prompt diagnosis difficult and possibly limited the treatment options available for the patient. Her lack of abdominal pain could be a result of the analgesia due to heroin use. It is also possible that abdominal pain might have been overlooked in favor of the chief complaint – right leg pain.
The diagnosis of amphetamine and heroin induced renal infarct is based on the rule out of other less likely possibilities. The patient denied use of any injectable drugs and did not have signs of systemic infection leading to septic emboli. Vasculitis was very unlikely based on the very low erythrocyte sedimentation rate. Eosinophils were within normal limits, ruling out hyper-eosinophilic syndrome leading to thrombosis. Hypercoagulable workup was negative in the patient as well. It is possible that she might have an extremely rare variant that is not detected by the standard hypercoagulable workup. However, this appears to be less likely than the renal infarction being secondary to the abuse of amphetamine and heroin. Both heroin and amphetamine contribute to hypercoagulability and vasculopathy and they likely promote a sequalae leading to renal infarction. It is even possible that some of the mechanisms elicited by these drugs might even work synergistically and the combination of amphetamine and heroin is even more likely to induce ischemic events such as renal infarctions. Consideration regarding including this diagnosis on a differential in patients using both of these drugs should be made, especially since the number of amphetamine and heroin users only appears to be increasing [5].

Acknowledgements

Not applicable.

Footnotes

Implication for health policy/practice/research/medical education: This case helps to understand renal infarction secondary to amphetamine and heroin abuse that could be overlooked in the population at risk leading to delay of appropriate care.

Declarations

Written informed consent to participate obtained from patient.
Written informed consent for publication obtained from patient.

Competing interests

Not Applicable.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Adle-Biassette H, et al. Cerebral infarctions in a drug addict inhaling heroin. Arch Anat Cytol Pathol. 1996;44(1):12–7.PubMed Adle-Biassette H, et al. Cerebral infarctions in a drug addict inhaling heroin. Arch Anat Cytol Pathol. 1996;44(1):12–7.PubMed
2.
Zurück zum Zitat Antopolsky M, et al. Renal infarction in the ED: 10-year experience and review of the literature. Am J Emerg Med. 2012;30(7):1055–60.CrossRef Antopolsky M, et al. Renal infarction in the ED: 10-year experience and review of the literature. Am J Emerg Med. 2012;30(7):1055–60.CrossRef
3.
Zurück zum Zitat Bingham C, et al. Necrotizing renal vasculopathy resulting in chronic renal failure after ingestion of methamphetamine and 3, 4-methylenedioxymethamphetamine ('ecstasy'). Nephrol Dial Transplant. 1998;13(10):2654–5.CrossRef Bingham C, et al. Necrotizing renal vasculopathy resulting in chronic renal failure after ingestion of methamphetamine and 3, 4-methylenedioxymethamphetamine ('ecstasy'). Nephrol Dial Transplant. 1998;13(10):2654–5.CrossRef
4.
Zurück zum Zitat Bolz J, et al. Multiple cerebral infarctions in a young patient with heroin-induced hypereosinophilic syndrome. J Neurol Sci. 2015;356(1):193–5.CrossRef Bolz J, et al. Multiple cerebral infarctions in a young patient with heroin-induced hypereosinophilic syndrome. J Neurol Sci. 2015;356(1):193–5.CrossRef
5.
Zurück zum Zitat Bose, J., et al. "Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: results from the 2017 national survey on drug use and health." (2018). Bose, J., et al. "Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: results from the 2017 national survey on drug use and health." (2018).
6.
Zurück zum Zitat Bourgault M, et al. Acute renal infarction: a case series. Clin J Am Soc Nephrol. 2013;8(3):392–8.CrossRef Bourgault M, et al. Acute renal infarction: a case series. Clin J Am Soc Nephrol. 2013;8(3):392–8.CrossRef
7.
Zurück zum Zitat de Ligny BH, et al. Early loss of two renal grafts obtained from the same donor: role of ecstasy? Transplantation. 2005;80(1):153–6.CrossRef de Ligny BH, et al. Early loss of two renal grafts obtained from the same donor: role of ecstasy? Transplantation. 2005;80(1):153–6.CrossRef
8.
Zurück zum Zitat Silva D, Anne D, et al. Amphetamine-associated ischemic stroke: clinical presentation and proposed pathogenesis. J Stroke Cerebrovasc Dis. 2007;16(4):185–6.CrossRef Silva D, Anne D, et al. Amphetamine-associated ischemic stroke: clinical presentation and proposed pathogenesis. J Stroke Cerebrovasc Dis. 2007;16(4):185–6.CrossRef
9.
Zurück zum Zitat Dufour M, Payet C, Gillet A. Bilateral renal infarction and ecstasy. J Mal Vasc. 2014;39(4):285.CrossRef Dufour M, Payet C, Gillet A. Bilateral renal infarction and ecstasy. J Mal Vasc. 2014;39(4):285.CrossRef
10.
Zurück zum Zitat Fleckenstein AE, et al. New insights into the mechanism of action of amphetamines. Annu Rev Pharmacol Toxicol. 2007;47:681–98.CrossRef Fleckenstein AE, et al. New insights into the mechanism of action of amphetamines. Annu Rev Pharmacol Toxicol. 2007;47:681–98.CrossRef
11.
Zurück zum Zitat Fonseca AC, Ferro JM. Drug abuse and stroke. Curr Neurol Neurosci Rep. 2013;13(2):325.CrossRef Fonseca AC, Ferro JM. Drug abuse and stroke. Curr Neurol Neurosci Rep. 2013;13(2):325.CrossRef
12.
Zurück zum Zitat Gebhard C, et al. Amphetamines induce tissue factor and impair tissue factor pathway inhibitor: role of dopamine receptor type 4. Eur Heart J. 2010;31(14):1780–91.CrossRef Gebhard C, et al. Amphetamines induce tissue factor and impair tissue factor pathway inhibitor: role of dopamine receptor type 4. Eur Heart J. 2010;31(14):1780–91.CrossRef
13.
Zurück zum Zitat Gupta A, Kuperman M, Shah S. N-methylamphetamine (“Crystal Meth”)− Associated Acute Renal Cortical Necrosis. Kidney Int Rep. 2018;3(6):1473–6.CrossRef Gupta A, Kuperman M, Shah S. N-methylamphetamine (“Crystal Meth”)− Associated Acute Renal Cortical Necrosis. Kidney Int Rep. 2018;3(6):1473–6.CrossRef
14.
Zurück zum Zitat Ho EL, et al. Cerebrovascular complications of methamphetamine abuse. Neurocrit Care. 2009;10(3):295–305.CrossRef Ho EL, et al. Cerebrovascular complications of methamphetamine abuse. Neurocrit Care. 2009;10(3):295–305.CrossRef
15.
Zurück zum Zitat Huecker MR, Marraffa J. "Heroin." StatPearls: StatPearls Publishing; 2019. Huecker MR, Marraffa J. "Heroin." StatPearls: StatPearls Publishing; 2019.
16.
Zurück zum Zitat Karch SB, Drummer O. Karch’s pathology of drug abuse: CRC press; 2008. Karch SB, Drummer O. Karch’s pathology of drug abuse: CRC press; 2008.
17.
Zurück zum Zitat Khattab E, Shujaa A. Amphetamine abuse and acute thrombosis of left circumflex coronary artery. Int J Case Reports Images. 2013;4:698.CrossRef Khattab E, Shujaa A. Amphetamine abuse and acute thrombosis of left circumflex coronary artery. Int J Case Reports Images. 2013;4:698.CrossRef
18.
Zurück zum Zitat Moqaddam AH, Musavi SMRA, Khademizadeh K. Relationship of opium dependency and stroke. Addiction Health. 2009;1(1):6. Moqaddam AH, Musavi SMRA, Khademizadeh K. Relationship of opium dependency and stroke. Addiction Health. 2009;1(1):6.
19.
Zurück zum Zitat Ohta K, et al. Delayed ischemic stroke associated with methamphetamine use. J Emerg Med. 2005;28(2):165–7.CrossRef Ohta K, et al. Delayed ischemic stroke associated with methamphetamine use. J Emerg Med. 2005;28(2):165–7.CrossRef
20.
Zurück zum Zitat Papachristidis A, et al. Aortic thrombus causing myocardial infarction after recreational MDMA use. Eur Heart J Cardiovasc Imaging. 2016;17(10):1187.CrossRef Papachristidis A, et al. Aortic thrombus causing myocardial infarction after recreational MDMA use. Eur Heart J Cardiovasc Imaging. 2016;17(10):1187.CrossRef
21.
Zurück zum Zitat Reece AS, Hulse GK. Duration of opiate exposure as a determinant of arterial stiffness and vascular age in male opiate dependence: a longitudinal study. J Clin Pharm Ther. 2014;39(2):158–67.CrossRef Reece AS, Hulse GK. Duration of opiate exposure as a determinant of arterial stiffness and vascular age in male opiate dependence: a longitudinal study. J Clin Pharm Ther. 2014;39(2):158–67.CrossRef
22.
Zurück zum Zitat Tatli E, Aktoz M. Heroin Abuse and Myocardial Infarction. Trakya Universitesi Tip Fakultesi Dergisi. 2010;27(2):212. Tatli E, Aktoz M. Heroin Abuse and Myocardial Infarction. Trakya Universitesi Tip Fakultesi Dergisi. 2010;27(2):212.
23.
Zurück zum Zitat Weiss SR, et al. Intracerebral and subarachnoid hemorrhage following use of methamphetamine (" speed"). Int Surg. 1970;53(2):123.PubMed Weiss SR, et al. Intracerebral and subarachnoid hemorrhage following use of methamphetamine (" speed"). Int Surg. 1970;53(2):123.PubMed
24.
Zurück zum Zitat Welling TH, Williams DM, Stanley JC. Excessive oral amphetamine use as a possible cause of renal and splanchnic arterial aneurysms: a report of two cases. J Vasc Surg. 1998;28(4):727–31.CrossRef Welling TH, Williams DM, Stanley JC. Excessive oral amphetamine use as a possible cause of renal and splanchnic arterial aneurysms: a report of two cases. J Vasc Surg. 1998;28(4):727–31.CrossRef
Metadaten
Titel
A rare case of renal infarction due to heroin and amphetamine abuse: case report
verfasst von
Suhail Khokhar
Daniela Garcia
Rajesh Thirumaran
Publikationsdatum
01.12.2022
Verlag
BioMed Central
Erschienen in
BMC Nephrology / Ausgabe 1/2022
Elektronische ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-021-02642-1

Weitere Artikel der Ausgabe 1/2022

BMC Nephrology 1/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.